SLC20A1P2

Across TCGA pan-cancer cohorts, SLC20A1P2 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated SLC20A1P2 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher SLC20A1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLC20A1P2 expression acts as an unfavorable survival marker, although some lineages such as LUAD and THYM show a favorable association.

KIRP, LUAD, and THYM are the cancer types where SLC20A1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.262	0.643	<.001	48	view →
LUAD	DFS	Tertile	All	0.808	0.625	<.001	30	view →
THYM	DFS	Tertile	All	0.930	0.468	.003	26	view →
DLBC	DFS	Tertile	III,IV	0.137	0.790	<.001	18	view →
HNSC	DFS	Tertile	All	0.755	0.292	.016	12	view →
LUSC	OS	Tertile	All	0.551	0.689	.016	12	view →
SKCM	DFS	Tertile	All	0.730	0.607	.039	9	view →
STAD	OS	Tertile	All	0.537	0.692	.014	9	view →
ESCA	DFS	Tertile	II,III,IV	0.697	0.442	.009	9	view →
READ	OS	Tertile	All	0.637	0.916	.027	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

SLC20A1P2–KIRP (DFS)

Open the KIRP breakdown →